| 1999 |
FACT complex is a heterodimer of human SPT16 (hSpt16) and SSRP1; it acts as a chromatin-specific transcription elongation factor, interacts with nucleosomes and histone H2A/H2B dimers, and promotes nucleosome disassembly to facilitate transcription elongation through chromatin templates in vitro. FACT activity is abrogated by covalently crosslinking nucleosomal histones. |
Biochemical purification, in vitro transcription reconstitution on chromatin templates, nucleosome binding assays, crosslinking experiments |
Nature |
High |
10421373
|
| 2001 |
SSRP1 (as part of FACT, a heterodimer with hSpt16) forms a UV-activated kinase complex with CK2 that selectively phosphorylates p53 at Ser-392 in vitro. FACT alters the substrate specificity of CK2 such that it preferentially phosphorylates p53 over other CK2 substrates including casein. Phosphorylation by this complex enhances p53 transcriptional activity. |
Biochemical purification of UV-activated kinase complex, in vitro kinase assay, identification of complex components by mass spectrometry/sequencing |
Molecular cell |
High |
11239457
|
| 2002 |
hSPT16 and SSRP1 interact via non-overlapping domains in vitro and in cells; binding of hSPT16 and SSRP1 to CK2 changes CK2 conformation to specifically target p53 Ser-392 over other substrates. UV irradiation induces assembly of the CK2·hSPT16·SSRP1 complex, increasing specificity of CK2 for p53 at Ser-392. |
Co-immunoprecipitation, in vitro binding assays, domain mapping, in vitro kinase assay |
The Journal of biological chemistry |
Medium |
12393879
|
| 2001 |
The FACT complex (SSRP1/Spt16 heterodimer) exhibits affinity and specificity for cisplatin-damaged DNA, binding the major 1,2-d(GpG) intrastrand adduct. The isolated SSRP1 subunit alone fails to form discrete high-affinity complexes with cisplatin-modified DNA, suggesting Spt16 primes SSRP1 for cisplatin-damaged DNA recognition by unveiling its HMG domain. The isolated HMG domain of SSRP1 alone is sufficient for specific binding to cisplatin-damaged DNA. |
Gel mobility shift assays (EMSA) with cisplatin-damaged DNA, testing FACT complex, isolated SSRP1, and isolated HMG domain |
The Journal of biological chemistry |
Medium |
11344167
|
| 2003 |
CK2 phosphorylates maize SSRP1 at multiple C-terminal residues including two sites adjacent to the HMG box domain; this phosphorylation induces a conformational change in the HMG box region (detected by circular dichroism) and switches on recognition of UV-damaged DNA by SSRP1 (non-phosphorylated SSRP1 does not discriminate between UV-damaged and control DNA). |
In vitro kinase assay with CK2α, acetic acid-urea PAGE, mass spectrometry phosphosite mapping, circular dichroism, DNA binding assays with UV-damaged DNA |
The Journal of biological chemistry |
Medium |
12571244
|
| 2005 |
CK2 phosphorylates SSRP1 at serines 510, 657, and 688 in vitro; phosphorylation inhibits the nonspecific DNA-binding activity of SSRP1 and FACT. Ser-510 is the most critical site for this regulation. SSRP1 is also phosphorylated in cells in response to UV (but not gamma) irradiation. |
In vitro CK2 kinase assay, peptide array kinase assay, site-directed mutagenesis (S510A/S657A/S688A), EMSA DNA-binding assays, metabolic 32P-labeling in cells |
The Journal of biological chemistry |
High |
15659405
|
| 2002 |
SSRP1 functions as a co-activator of p63 by direct physical interaction (in vitro and in cells); it binds p63γ through its central domain, and ectopic expression of full-length SSRP1 (but not deletion mutants) enhances p63γ-dependent transcription, G1 arrest, apoptosis, and expression of endogenous p53 target genes. SSRP1 co-occupies p53-responsive elements of MDM2 and p21 promoters with p63γ. |
Co-immunoprecipitation, in vitro GST pulldown, luciferase reporter assays, chromatin immunoprecipitation (ChIP), cell-based gain/loss-of-function |
The EMBO journal |
Medium |
12374749
|
| 1999 |
SSRP1 interacts with SRF (serum response factor) through the MADS box of SRF and a basic region of SSRP1 (amino acids 489–542 adjacent to the HMG domain); this interaction dramatically increases the DNA-binding activity of SRF and results in synergistic transcriptional activation of SRF-dependent promoters. SSRP1 itself does not bind the CArG box. |
Yeast one-hybrid screen, co-immunoprecipitation in mammalian cells, EMSA, luciferase reporter assays, domain mapping |
The Journal of biological chemistry |
Medium |
10336466
|
| 1999 |
CHD1 interacts in vivo with SSRP1 via an amino-terminal segment of CHD1 that does not include the chromodomain; CHD1 and SSRP1 co-localize in mammalian nuclei and at transcriptionally active regions of Drosophila polytene chromosomes. |
Co-immunoprecipitation (in vivo), immunocytochemistry/immunofluorescence co-localization |
Chromosoma |
Medium |
10199952
|
| 2001 |
In yeast, the bipartite FACT analog composed of Cdc68 (Spt16), Pob3, and Nhp6 functionally recapitulates the vertebrate FACT complex; Nhp6 (the yeast functional analog of the SSRP1 HMG domain) associates with the CP complex and provides HMG box functions for transcription elongation. An artificial Pob3-Nhp6a fusion protein (mimicking SSRP1) restores both Pob3 and Nhp6a functions. |
Genetic epistasis (double mutant analysis), 6-azauracil sensitivity, protein fusion complementation, co-immunoprecipitation |
Molecular and cellular biology |
Medium |
11313475
|
| 2003 |
Ssrp1 homozygous knockout in mice causes embryonic lethality at day 3.5, with preimplantation blastocysts defective for cell outgrowth/survival in vitro. This lethality is p53-independent (crosses with p53-null background do not rescue), establishing nonredundant, essential functions for SSRP1 in early cell viability. |
Gene targeting in mouse ES cells, germline transmission, embryo outgrowth assays, p53-null genetic background cross |
Molecular and cellular biology |
High |
12861016
|
| 2007 |
SSRP1 has both SPT16-dependent and SPT16-independent roles in transcription regulation in human cells; approximately 1.3% of assayed genes are co-regulated by both SSRP1 and Spt16, while a distinct subset is regulated by SSRP1 alone. Both SSRP1 and Spt16 are required for progression of elongating RNA Pol II on the egr1 gene. |
Spotted microarray after siRNA knockdown of SSRP1 or Spt16, chromatin immunoprecipitation for elongating Pol II |
The Journal of biological chemistry |
Medium |
17209051
|
| 2009 |
SSRP1 physically interacts with the HR repair protein Rad54 both in vitro and in vivo; SSRP1 inhibits Rad54-promoted branch migration of Holliday junctions in vitro. Knockdown of SSRP1 increases HR frequency and Rad51/H2AX foci, while overexpression reduces HU-induced Rad51 foci, indicating SSRP1 suppresses inappropriate homologous recombination repair. |
Co-immunoprecipitation (in vivo), in vitro pulldown, branch migration assay with Holliday junctions, hprt recombination assay, immunofluorescence for Rad51/γH2AX foci, siRNA knockdown and overexpression |
Journal of cellular biochemistry |
Medium |
19639603
|
| 2009 |
SSRP1 (as a FACT subunit) binds the KSHV latent origin replication element and forms a complex with LANA at this origin; siRNA knockdown of SSRP1 significantly reduces the efficiency of LANA-dependent latent DNA replication. |
Biotinylated DNA pulldown/affinity purification to identify origin-binding proteins, Co-immunoprecipitation, siRNA knockdown with plasmid replication efficiency assay |
Journal of virology |
Medium |
19710137
|
| 2006 |
SSRP1 is cleaved during apoptosis by caspase 3 and/or caspase 7 at the DQHD450 site, generating a truncated chromatin-associated form of FACT. The N-terminal cleavage product is subsequently degraded via the ubiquitin-proteasome pathway (stabilized by proteasome inhibitors and ubiquitylated in cells). |
In vitro caspase cleavage assay, site-directed mutagenesis of caspase site, proteasome inhibitor treatment, ubiquitylation assay in cells, cellular fractionation |
Cell death and differentiation |
Medium |
16498457
|
| 2015 |
Crystal structure of the SSRP1 middle domain reveals tandem pleckstrin homology (PH) domains (PH1 with an extra conserved βαβ topology); the middle domain participates in DNA binding via a positively charged patch on its surface, but does not bind histones (negative result confirmed by pulldown assay). |
X-ray crystallography, DNA binding assays, histone pulldown assays |
Scientific reports |
High |
26687053
|
| 2015 |
FACT components SUPT16H and SSRP1 suppress HIV-1 transcription and promote viral latency; SUPT16H (but not SSRP1) directly interacts with HIV-1 Tat protein, yet both are recruited to the HIV-1 LTR promoter. SUPT16H interferes with association of Cyclin T1 (a P-TEFb subunit) with the Tat-LTR axis. Depletion of either SSRP1 or SUPT16H spontaneously reverses HIV-1 latency. |
RNAi functional genomic screen, Co-immunoprecipitation, HIV-1 LTR reporter assay, ChIP, latency reversal assays in U1/HIV, J-LAT cells, and primary CD4+ T cell model |
The Journal of biological chemistry |
Medium |
26378236
|
| 2017 |
SSRP1 is recruited to DNA single-strand break (SSB) sites in a PARP-dependent manner and is retained at damage sites via N-terminal interactions with XRCC1. SSRP1 (but not SPT16) is specifically required for chromatin decondensation and histone H2B exchange at SSB sites, which primes chromatin for efficient SSB repair and cell survival after ionizing radiation or MMS treatment. |
Live-cell imaging (laser microirradiation recruitment), co-immunoprecipitation, domain mutational analysis, siRNA knockdown with survival assay, histone exchange (FRAP), chromatin decondensation assay |
Cancer research |
High |
28416484
|
| 2018 |
SSRP1 forms an elongated homodimer in solution (characterized by AUC and SAXS); homodimerization involves the PH2 region, the same surface used for heterodimerization with SPT16, suggesting homo- and heterodimerization are mutually exclusive. SSRP1 homodimerization promotes binding to both histones H2A-H2B and H3-H4 (isothermal titration calorimetry); disruption of homodimerization decreases histone-binding affinity. |
Analytical ultracentrifugation (AUC), small-angle X-ray scattering (SAXS), isothermal titration calorimetry (ITC), site-directed mutagenesis |
The Journal of biological chemistry |
High |
29764934
|
| 2020 |
SSRP1 promotes replication origin assembly on somatic chromatin in Xenopus by evicting histone H1 via its N-terminal domain; histone H1 removal derepresses ORC and MCM chromatin binding, enabling efficient replication origin firing. SSRP1 protein decays at mid-blastula transition (MBT), and increased SSRP1 levels delay MBT and accelerate post-MBT cell cycle speed and embryo development. |
Xenopus laevis egg extract replication assays, chromatin fractionation, siRNA/antibody depletion of SSRP1 and H1, domain mutational analysis, embryo microinjection |
Nature communications |
High |
32165637
|
| 2016 |
Depletion of SSRP1 in human mesenchymal stem cells decreases expression of osteoblast-specific genes and downregulates Wnt pathway target genes, accompanied by decreased nuclear localization of active β-catenin, identifying a role for SSRP1 in promoting Wnt signaling pathway activity during osteoblast differentiation. |
siRNA knockdown in human MSCs, RNA-seq, Western blot for active β-catenin nuclear localization, differentiation assays |
Stem cells |
Medium |
27146025
|
| 2024 |
TRIB3 directly interacts with SSRP1 and USP10, forming a TRIB3/USP10/SSRP1 ternary complex; USP10-mediated deubiquitination stabilizes SSRP1 protein, and TRIB3 enhances this deubiquitinating effect. A stapled peptide (SP-A) disrupts the TRIB3/USP10/SSRP1 complex and promotes SSRP1 degradation. |
Co-immunoprecipitation, ubiquitination assays, in vivo and in vitro interaction studies, peptide disruption assay |
Oncogene |
Medium |
39653795
|
| 1998 |
SSRP1 (identified as PREIIBF) binds with sequence specificity to a 19-bp positive regulatory element (PRE II) in the human embryonic ε-globin gene promoter, bends the target DNA, and is required for promoter activation in stable erythroid cell lines. This is the first evidence that SSRP1 plays a direct role in transcriptional regulation via sequence-specific DNA binding. |
cDNA expression cloning, EMSA (gel shift with specific DNA competition), DNA bending assay (circularization), stable transfection reporter assay in erythroid cells |
Molecular and cellular biology |
Medium |
9566881
|
| 2023 |
SSRP1 maintains mitochondrial oxidative respiration in hepatocellular carcinoma cells by transcriptionally promoting expression of TRAP1 (the mitochondrial HSP90 family member); SSRP1 occupies the TRAP1 promoter (by ChIP), and SSRP1 knockdown decreases TRAP1 mRNA and protein, reduces mitochondrial oxidative respiration, and causes mitochondrial damage. |
siRNA knockdown, ChIP assay, qRT-PCR, Western blot, mitochondrial respiration assay (Seahorse), rescue experiments |
Biochemistry and cell biology |
Medium |
37084412
|
| 2024 |
The FACT complex (hSpt16/SSRP1) mediates the FEAR (FACT-ETS-1 Antiviral Response) pathway, remodeling chromatin to activate expression of the antiviral transcription factor ETS-1 to restrict RNA virus (VSV and paramyxovirus) replication. VSV M protein promotes proteasome-dependent degradation of SUMOylated hSpt16 to counter FEAR; this antagonism of SUMOylated Spt16 by viral proteins is a conserved mechanism across DNA and RNA viruses. |
siRNA depletion of hSpt16/SSRP1, viral replication assays, mutant M protein analysis, genetic rescue experiments |
bioRxiv (preprint)preprint |
Medium |
bio_10.1101_2024.08.22.609092
|